Abalos Therapeutics GmbH Revenue and Competitors
Estimated Revenue & Valuation
- Abalos Therapeutics GmbH's estimated annual revenue is currently $3.6M per year.
- Abalos Therapeutics GmbH's estimated revenue per employee is $155,000
Employee Data
- Abalos Therapeutics GmbH has 23 Employees.
- Abalos Therapeutics GmbH grew their employee count by -15% last year.
Abalos Therapeutics GmbH's People
| Name | Title | Email/Phone |
|---|
Abalos Therapeutics GmbH Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $36.9M | 238 | 9% | N/A | N/A |
#2 | $33.7M | 174 | -10% | $521.9M | N/A |
#3 | $52.4M | 338 | 15% | N/A | N/A |
#4 | $162.7M | 1219 | 33% | N/A | N/A |
#5 | $43.2M | 279 | 7% | N/A | N/A |
#6 | $1.1M | 7 | N/A | N/A | N/A |
#7 | $24.2M | 156 | 10% | N/A | N/A |
#8 | $19.7M | 127 | 8% | N/A | N/A |
#9 | $21.2M | 137 | 12% | $347.1M | N/A |
#10 | $18.3M | 118 | 7% | $197.4M | N/A |
What Is Abalos Therapeutics GmbH?
Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system's power specifically against cancer cells. Through viral replication within cancer cells, Abalos' arenavirus-based drug candidates are designed to awake precise innate and adaptive immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos' goal is to achieve a quantum leap in immuno-oncology.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Düsseldorf
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.4M | 24 | -4% | N/A |
#2 | $5.1M | 27 | 8% | N/A |
#3 | $5.3M | 28 | -24% | N/A |
#4 | $5.3M | 28 | -24% | N/A |
#5 | $8M | 32 | 10% | N/A |